Suchergebnisse - "Langer, Jakob"

PubPharm (9)

1

Long-term cost-effectiveness analysis shows that IDegLira is associated with improved outcomes and lower costs compared with insulin glargine U100 plus insulin aspart in the US

enthalten in: Journal of medical economics | 2018

von Dempsey, M. | Mocarski, M. | Langer, J. | +1

2

IDegLira Versus Insulin Glargine U100 : A Long-term Cost-effectiveness Analysis in the US Setting

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

3

Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA

enthalten in: Advances in therapy | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

ErratumIn: Adv Ther. 2017 Jun;34(6):1500-1501. - PMID 28523624

4

IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting

enthalten in: Diabetes therapy | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

5

IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting

enthalten in: Diabetes therapy | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

6

IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting

enthalten in: Diabetes therapy | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

7

Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA

enthalten in: Advances in therapy | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

8

Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA

enthalten in: Advances in therapy | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

9

Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Continued Up-Titration of Insulin Glargine U100 in Patients with Type 2 Diabetes in the USA

enthalten in: Advances in therapy | 2017

von Hunt, B. | Mocarski, M. | Valentine, W. | +1

1
[1]